China Universal Asset Management »

Kalvista Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $95k 8.0k 11.84
2023-12-31 $49k 4.0k 12.31
2022-09-30 $3.0k 230 13.04

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Frazier Life Sciences Management
Tang Capital Management
Vanguard Group
Boxer Capital
Caption Management
Citadel Advisors
Dimensional Fund Advisors
DAFNA Capital Management
Goldman Sachs Group
Rosalind Advisors
Citigroup
Two Sigma Advisers
Two Sigma Investments
Opaleye Management

View all funds holding Kalvista Pharmaceuticals